Format

Send to

Choose Destination
See comment in PubMed Commons below
Antimicrob Agents Chemother. 2007 Dec;51(12):4489-91. Epub 2007 Sep 17.

Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase.

Author information

  • 1Department of Virology, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom.

Abstract

We describe an unusual pathway of human immunodeficiency virus type 1 reverse transcriptase resistance during therapy with tenofovir-emtricitabine, characterized initially by the mutations K70E and M184V and later by K70G and M184V, with the two mutations coexisting on the same viral genome. Phenotypic resistance to lamivudine, emtricitabine, abacavir, didanosine, and tenofovir was observed, whereas susceptibility to zidovudine and stavudine was preserved.

PMID:
17876005
PMCID:
PMC2167988
DOI:
10.1128/AAC.00687-07
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center